The short version
Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now — FDA lists the reason as “other”.
Market view
technetium tc99m pyrophosphate · Injection
2 marketed package NDCs · 1 active manufacturer
Same drug class
Other molecules FDA puts in Radioactive Diagnostic Agent, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- choline c-11· 1 maker
- copper cu 64 dotatate· 1 maker
- florbetaben f 18· 1 maker
- florbetapir f 18· 1 maker
- flotufolastat f-18· 1 maker
- fluciclovine f-18· 1 maker
- fluoroestradiol f 18· 1 maker
- flurpiridaz f-18· 1 maker
- flutemetamol f-18· 1 maker
- kit for the preparation of technetium tc 99m exametazime for leukocyte labeling· 1 maker
- kit for the preparation of technetium tc99m sestamibi· 1 maker
- rubidium chloride rb-82· 1 maker
Common questions
- Is Technetium tc99m pyrophosphate in shortage right now?
- Yes. FDA currently lists Technetium tc99m pyrophosphate in shortage, with the reason given as "other". This page is rebuilt every morning from FDA's shortage database.
- Who makes Technetium tc99m pyrophosphate?
- 1 company has marketed Technetium tc99m pyrophosphate in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
Shortage reports for this molecule
- In shortage now — CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-1)Dec 27, 2023
- In shortage now — CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-2)Dec 27, 2023
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.